10 ADVANCE FOR MEDICAL LABORATORY PROFESSIONALS COVER STORY FEBRUARY/MARCH 2016 remaining measures, such as CPOE for lab orders and reporting lab results to public health agencies. As the final rule significantly eased the most difficult measures for providers-patient engagement and secure messaging-CPOE compliance will quickly become a top priority. Previous Stage 1 providers, in particular, who are new to entering lab orders through CPOE, may need to increase the number of labs that they are interfaced with in order to meet the 30% threshold. Laboratories should ensure they are prepared to adhere to MU interface standards, such as LOINC, HL7 and SNOMED CT, in order to take advantage of new and existing business opportunities. n EH & EP Modified Stage 2 Measure: More than 60% of medication, 30% of laboratory and 30% of radiology orders created during the EHR reporting period are recorded using CPOE. n EH Modified Stage 2 Measure: EHs must select 3 public health measures and EPs must select 2. The reportable lab results option is for EHs only-the EH is in active engagement with a public health agency to submit electronic reportable laboratory (ELR) results. A GLIMPSE AT STAGE 3 The final rule also details MU requirements for Stage 3 which, despite the name, are certainly not final. The rules and regulations surrounding Stage 3 will undergo formal review through a 60 day comment period and, ultimately, the publication of a Stage 3 specific final ruling. The proposal indicates that Stage 3 will be optional for providers in 2017 and mandatory for all providers beginning in 2018. The new program requirements will be a steep climb from Modified Stage 2, with new certification standards, increased compliance thresholds and additional measures. All providers will need to be on a 2015 certified EHR prior to the start of the 2018 reporting period, which places significant pressure on EHR vendors and those aligned with provider systems. Once again, the aggressive timeline will exacerbate the need for resources specialized in maintaining and enhancing the interoperability of systems. Laboratories prepared to handle this demand will surely thrive in the future years of Meaningful Use. Jenna Barsky is a consulting manager at WeiserMazars, LLP. Contact jenna.barsky@weiserma zars.com New Lab Medicine Building to open in 2017 At Memorial Sloan Kettering, our success is measured in the steps we take every day to prevent, detect and treat cancer. Located in the heart of NYC, we’re consistently ranked as one of the nation’s top cancer centers by U.S.News & World Report. LABORATORY MEDICINE LEADERSHIP OPPORTUNITIES In our state-of-the-art clinical laboratories, you’ll find the sophisticated technology and automated equipment you need to get to the answers faster and more efficiently. We’re pushing the limits of science and technology, join us and make the next breakthrough. Join our Online Talent Community OR apply online at careers.mskcc.org NOW HIRING Assistant Manager, Microbiology Assistant Manager, Flow Cytometry Supervisor, Cell Therapy LIS Systems Analyst Memorial Sloan Kettering is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply.
ADVANCE for Medical Laboratory Professionals • February/March 2016
To see the actual publication please follow the link above